In this Q&A, Avitzur breaks down the study’s findings and suggests how the information can be used to advance PF research and treatments. This transcript has been lightly edited for clarity. AJMC: ...

Traction bronchiectasis on computed tomography and body mass index were significantly associated with PPF, while radiological and symptomatic progression and older age were significantly associated ...

Iron Lung' from YouTube celebrity Markiplier flatters his directing and acting skills, but the claustrophobic sci-fi horror ...

Mike Burnett was diagnosed with Idiopathic Pulmonary Fibrosis in 2023 and needs a double lung transplant to survive.

She never wanted anyone to have to naively be in pain without answers," Dern tells PEOPLE of her mother, who died in November ...

Artificial intelligence has come a long way, writes columnist Sam Kirton, who argues for its role in medicine and in his own care with PF.

TUESDAY, Dec. 30, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults. Jascayd ...

WILLARD, Mo. — Willard Police Chief Tom McClain has been in law enforcement for many decades, and has been the leader of Willard’s police force since 1993. He’s fought crime for years, but now, he’s ...

Environmental factors including temperature, humidity, air quality, and seasonal changes can significantly impact idiopathic pulmonary fibrosis (IPF). These triggers can exacerbate symptoms and lead ...

Following the recent approval of nerandomilast tablets for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, the FDA has approved the medication for progressive pulmonary fibrosis as ...

What Is Jascayd, and Why Does It Matter? Jascayd (nerandomilast) is now approved for treating adults with progressive pulmonary fibrosis (PPF) that causes gradual and permanent scarring in the lungs, ...

Barreling toward the end of its cash runway, GRI Bio has shared phase 2a data in idiopathic pulmonary fibrosis (IPF) and made the case for further development of its potentially disease-modifying ...